Literature DB >> 30680812

A Highly Efficient Tumor-Targeting Nanoprobe with a Novel Cell Membrane Permeability Mechanism.

Zhendong Lei1,2, Lin Ding1, Chenjie Yao1,3, Fengfeng Mo4, Chenchen Li1, Yanan Huang1, Xuelian Yin1, Min Li4, Jinliang Liu1, Yong Zhang1,2, Changquan Ling5, Yanli Wang1,3.   

Abstract

Efficient tumor targeting has been a great challenge in the clinic for a very long time. The traditional targeting methods based on enhanced permeability and retention (EPR) effects show only an ≈5% targeting rate. To solve this problem, a new graphene-based tumor cell nuclear targeting fluorescent nanoprobe (GTTN), with a new tumor-targeting mechanism, is developed. GTTN is a graphene-like single-crystalline structure amphiphilic fluorescent probe with a periphery that is functionalized by sulfonic and hydroxyl groups. This probe has the characteristic of specific tumor cell targeting, as it can directly cross the cell membrane and specifically target to the tumor cell nucleus by the changed permeability of the tumor cell membranes in the tumor tissue. This new targeting mechanism is named the cell membrane permeability targeting (CMPT) mechanism, which is very different from the EPR effect. These probes can recognize tumor tissue at a very early stage and track the invasion and metastasis of tumor cells at the single cell level. The tumor-targeting rate is improved from less than 5% to more than 50%. This achievement in efficient and accurate tumor cell targeting will speed up the arrival of a new era of tumor diagnosis and treatment.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cell membrane permeability; fluorescent nanoprobes; tumor cell nuclear targeting

Mesh:

Substances:

Year:  2019        PMID: 30680812     DOI: 10.1002/adma.201807456

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  6 in total

1.  Stimuli-Responsive Plasmonic Assemblies and Their Biomedical Applications.

Authors:  Qinrui Fu; Zhi Li; Fengfu Fu; Xiaoyuan Chen; Jibin Song; Huanghao Yang
Journal:  Nano Today       Date:  2020-11-08       Impact factor: 20.722

2.  Magnetic targeted near-infrared II PA/MR imaging guided photothermal therapy to trigger cancer immunotherapy.

Authors:  Qinrui Fu; Zhi Li; Jiamin Ye; Zhong Li; Fengfu Fu; Syue-Liang Lin; Cheng Allen Chang; Huanghao Yang; Jibin Song
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

3.  Biocompatible nucleus-targeted graphene quantum dots for selective killing of cancer cells via DNA damage.

Authors:  Lei Qi; Tonghe Pan; Liling Ou; Zhiqiang Ye; Chunlei Yu; Bijun Bao; Zixia Wu; Dayong Cao; Liming Dai
Journal:  Commun Biol       Date:  2021-02-16

4.  Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer.

Authors:  Ziyu Meng; Binchao Wang; Yiqiang Liu; Yejian Wan; Qianshi Liu; Huasheng Xu; Renchuan Liang; Ying Shi; Peng Tu; Hong Wu; Chuan Xu
Journal:  Regen Biomater       Date:  2022-08-01

Review 5.  Tumor immunotherapy and multi-mode therapies mediated by medical imaging of nanoprobes.

Authors:  Yang Xuan; Meng Guan; Shubiao Zhang
Journal:  Theranostics       Date:  2021-05-25       Impact factor: 11.556

Review 6.  Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies.

Authors:  Guangman Cui; Junrong Wu; Jiaying Lin; Wenjing Liu; Peixian Chen; Meng Yu; Dan Zhou; Guangyu Yao
Journal:  J Nanobiotechnology       Date:  2021-07-15       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.